Biodegradable Gel Being Studied As Treatment For Esophageal Cancer, Rush University Medical Center Study

Published: Apr 20, 2009

ScienceDaily (Apr. 20, 2009) — Gastroenterologists at Rush University Medical Center are studying the safety and efficacy of a new system for delivering chemotherapy for patients with esophageal cancer, a rare, but deadly disease that attacks the throat. The unique drug therapy delivers a highly concentrated dose of chemotherapy injected directly on to the hard-to-reach tumors in the esophagus non-surgically.

Back to news